Shandong Buchang Pharmaceuticals Co Ltd Cash Flow Conversion Efficiency
Shandong Buchang Pharmaceuticals Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shandong Buchang Pharmaceuticals Co Ltd (603858) has a cash flow conversion efficiency ratio of -0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-145.26 Million ≈ $-21.26 Million USD) by net assets (CN¥10.07 Billion ≈ $1.47 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Cash flow conversion efficiency of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. This chart illustrates how Shandong Buchang Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Buchang Pharmaceuticals Co Ltd share price for real-time trading data and today's change.
Shandong Buchang Pharmaceuticals Co Ltd Cash Flow Conversion Ratio Explained
Shandong Buchang Pharmaceuticals Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shandong Buchang Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Buchang Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. Also see 603858 market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Suntien Green Energy Corp Ltd
SHG:600956
|
0.093x |
|
Shufersal
TA:SAE
|
0.022x |
|
Vietnam Airlines JSC
VN:HVN
|
-0.690x |
|
Shake Shack Inc
NYSE:SHAK
|
0.054x |
|
Newell Brands Inc
NASDAQ:NWL
|
0.012x |
|
iRay Technology Co Ltd
SHG:688301
|
0.057x |
|
Shenzhen FRD Science & Technology Co Ltd
SHE:300602
|
0.042x |
|
PT Golden Energy Mines Tbk
JK:GEMS
|
0.053x |
Annual Cash Flow Conversion Efficiency for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. Review 603858 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥9.81 Billion ≈ $1.44 Billion |
CN¥939.95 Million ≈ $137.54 Million |
0.096x | +763.71% |
| 2023-12-31 | CN¥11.38 Billion ≈ $1.66 Billion |
CN¥-164.26 Million ≈ $-24.04 Million |
-0.014x | -106.43% |
| 2022-12-31 | CN¥12.28 Billion ≈ $1.80 Billion |
CN¥2.76 Billion ≈ $403.23 Million |
0.224x | +145.65% |
| 2021-12-31 | CN¥14.45 Billion ≈ $2.11 Billion |
CN¥1.32 Billion ≈ $193.23 Million |
0.091x | -35.57% |
| 2020-12-31 | CN¥13.81 Billion ≈ $2.02 Billion |
CN¥1.96 Billion ≈ $286.63 Million |
0.142x | -25.40% |
| 2019-12-31 | CN¥13.79 Billion ≈ $2.02 Billion |
CN¥2.62 Billion ≈ $383.58 Million |
0.190x | +28.47% |
| 2018-12-31 | CN¥13.86 Billion ≈ $2.03 Billion |
CN¥2.05 Billion ≈ $300.10 Million |
0.148x | -0.30% |
| 2017-12-31 | CN¥13.22 Billion ≈ $1.93 Billion |
CN¥1.96 Billion ≈ $287.10 Million |
0.148x | +13.09% |
| 2016-12-31 | CN¥12.71 Billion ≈ $1.86 Billion |
CN¥1.67 Billion ≈ $244.20 Million |
0.131x | -55.07% |
| 2015-12-31 | CN¥7.26 Billion ≈ $1.06 Billion |
CN¥2.12 Billion ≈ $310.33 Million |
0.292x | -27.01% |
| 2014-12-31 | CN¥4.45 Billion ≈ $651.08 Million |
CN¥1.78 Billion ≈ $260.56 Million |
0.400x | +53.90% |
| 2013-12-31 | CN¥4.28 Billion ≈ $626.87 Million |
CN¥1.11 Billion ≈ $163.01 Million |
0.260x | -22.48% |
| 2012-12-31 | CN¥4.02 Billion ≈ $588.56 Million |
CN¥1.35 Billion ≈ $197.43 Million |
0.335x | -39.43% |
| 2011-12-31 | CN¥2.80 Billion ≈ $409.96 Million |
CN¥1.55 Billion ≈ $227.05 Million |
0.554x | -- |
About Shandong Buchang Pharmaceuticals Co Ltd
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.